Conference
Prognostic and predictive value of topoisomerase II alpha in a randomized trial comparing CMF to CEF in premenopausal women with node positive breast cancer (NCIC CTG MA.5).
Authors
O'Malley FP; Chia S; Tu D; Shepherd LE; Levine MN; Huntsman DG; Bramwell VH; Andrulis IL; Pritchard KI
Volume
24
Pagination
pp. 11S-11S
Publisher
AMER SOC CLINICAL ONCOLOGY
Publication Date
June 20, 2006
Name of conference
42nd Annual Meeting of the American-Society-of-Clinical-Oncology
Conference place
Atlanta, GA
Conference start date
June 2, 2006
Conference end date
June 6, 2006
Conference proceedings
JOURNAL OF CLINICAL ONCOLOGY
Issue
18
ISSN
0732-183X